(VIANEWS) – The NASDAQ ended the session with Castle Biosciences (CSTL) rising 6.37% to $27.06 on Wednesday while NASDAQ jumped 1.58% to $11,897.65.


Today’s last reported volume for Castle Biosciences is 148213, 60.86% below its average volume of 378701.

Castle Biosciences’s last close was $25.44, 67.63% under its 52-week high of $78.58.

The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be overbought (>=80).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $27.06 at 18:36 EST, way under its 52-week high of $78.58 and way higher than its 52-week low of $15.58.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way above its 50-day moving average of $20.98 and way below its 200-day moving average of $39.80.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here